AMP Capital Investors Ltd Boosts Holdings in CIGNA Co. (NYSE:CI)

AMP Capital Investors Ltd grew its holdings in shares of CIGNA Co. (NYSE:CI) by 3.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 213,554 shares of the health services provider’s stock after buying an additional 6,596 shares during the period. AMP Capital Investors Ltd owned 0.09% of CIGNA worth $39,920,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its position in CIGNA by 40.8% in the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock worth $684,413,000 after buying an additional 1,184,632 shares during the last quarter. Investec Asset Management LTD grew its position in CIGNA by 35.4% during the 3rd quarter. Investec Asset Management LTD now owns 1,849,598 shares of the health services provider’s stock worth $345,764,000 after purchasing an additional 483,904 shares in the last quarter. FMR LLC grew its position in CIGNA by 6.7% during the 2nd quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after purchasing an additional 432,978 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in CIGNA by 4,082.8% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock worth $73,355,000 after purchasing an additional 427,754 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in CIGNA by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock worth $2,867,514,000 after purchasing an additional 424,469 shares in the last quarter. 87.74% of the stock is currently owned by institutional investors.

Shares of CIGNA Co. (CI) traded down $2.15 during mid-day trading on Friday, hitting $203.09. 736,245 shares of the stock were exchanged, compared to its average volume of 1,207,109. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39. The firm has a market capitalization of $50,601.86, a price-to-earnings ratio of 22.24, a price-to-earnings-growth ratio of 1.57 and a beta of 0.50. CIGNA Co. has a 12 month low of $133.11 and a 12 month high of $212.46.

CIGNA (NYSE:CI) last posted its earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.36 by $0.47. CIGNA had a net margin of 5.74% and a return on equity of 18.85%. The company had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. During the same period last year, the business posted $1.94 earnings per share. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. equities research analysts anticipate that CIGNA Co. will post 10.34 earnings per share for the current year.

Several research firms have weighed in on CI. Piper Jaffray Companies reiterated a “buy” rating and set a $191.00 price objective on shares of CIGNA in a research report on Sunday, September 17th. Royal Bank of Canada reissued an “outperform” rating and set a $220.00 target price (up previously from $185.00) on shares of CIGNA in a research note on Friday, November 3rd. Credit Suisse Group initiated coverage on shares of CIGNA in a research note on Thursday, November 2nd. They issued an “outperform” rating and a $219.00 price objective for the company. Morgan Stanley lifted their price objective on shares of CIGNA from $195.00 to $223.00 and gave the company an “overweight” rating in a research note on Friday, November 3rd. Finally, Jefferies Group lifted their price objective on shares of CIGNA from $201.00 to $221.00 and gave the company a “buy” rating in a research note on Friday, October 13th. Two investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $202.56.

In other CIGNA news, EVP Alan Muney sold 15,345 shares of the stock in a transaction on Monday, November 27th. The shares were sold at an average price of $200.80, for a total value of $3,081,276.00. Following the completion of the sale, the executive vice president now owns 28,457 shares in the company, valued at $5,714,165.60. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Chairman Isaiah Harris, Jr. sold 212 shares of the stock in a transaction on Monday, December 11th. The shares were sold at an average price of $209.35, for a total transaction of $44,382.20. The disclosure for this sale can be found here. Insiders have sold 34,936 shares of company stock valued at $6,979,204 in the last three months. 1.30% of the stock is owned by insiders.

COPYRIGHT VIOLATION WARNING: “AMP Capital Investors Ltd Boosts Holdings in CIGNA Co. (NYSE:CI)” was originally published by Week Herald and is the sole property of of Week Herald. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://weekherald.com/2017/12/30/amp-capital-investors-ltd-has-39-92-million-holdings-in-cigna-corporation-ci.html.

CIGNA Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply